Elranatamab
Product Specifications
CAS Number
2408850-14-4
Target
TNF
Related Pathways
Apoptosis
Bioactivity
Elranatamab (PF-06863135) is a humanized bispecific antibody that targets BCMA (B-cell maturation antigen) on myeloma cells and CD3 on T cells. By targeting these molecules, Elranatamab activates T cells and directs them to induce a cytotoxic T cell response against myeloma cells. This compound is used in research for relapsed or refractory multiple myeloma.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
BG-50-RF 20 mL - 1 OD
DiagNano™ Gold Nanoparticles, Reactant Free, 50 nm
Sign In for Pricing
View Details 
LV640111 1.0 µg DNA
CELF4 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details 
BA1141-0.5ml 0.5 mL
Goat Anti-Mouse IgG (H+L) Secondary Antibody, DyLight®594 Conjugated
Sign In for Pricing
View Details DZ41825-Fluoro550 200 µL/Vial
Anti-Aedes aegypti (Yellowfever mosquito) AeR2D2 Antibody Fluoro550 Conjugated
Sign In for Pricing
View Details